Skip to main content
. 2019 Jun 28;220(9):1435–1443. doi: 10.1093/infdis/jiz334

Table 2.

Clinical Correlates of Phosphatidylserine Immunoglobulin M and Immunoglobulin G Antibodies in Patients With Malaria

Plasmodium falciparum (n = 269) Plasmodium vivax (n = 176)
PS IgM PS IgG PS IgM PS IgG
Clinical Correlate Correlation P Value Correlation P Value Correlation P Value Correlation P Value
Hb on enrollment –0.27 < .0001a –0.26 < .0001a –0.30 .001 –0.31 < .0001a
Hb nadir –0.28 < .0001a –0.29 < .0001a –0.34 < .0001 –0.35 < .0001a
Parasite count –0.00 .943 0.01 .824 0.10 .170 0.10 .192
Fever duration 0.30 < .0001 0.11 .078 0.22 .004 0.15 .051
Age 0.11 .067 –0.06 .358 –0.21 .005 –0.23 .002
CFHbb 0.19 .014 0.27 .027 0.04 .779 –0.07 .601
RBC-Dc (at 1.7 Pa) –0.28 .008 –0.13 .227 0.22 .282 –0.04 .859
RBC-Dc (at 30 Pa) –0.21 .050 –0.18 .085 –0.05 .828 –0.28 .176

Abbreviations: CFHb, cell-free hemoglobin; Hb, hemoglobin; IgG, immunoglobulin G; IgM, immunoglobulin M; PS, phosphatidylserine; RBC-D, red blood cell deformability.

aRemained significant after controlling for parasitemia, fever duration, and age (Supplementary Table 1).

bCFHb was measured in 133 patients with falciparum malaria and 57 with vivax malaria.

cRBC-D was measured in 90 patients with falciparum malaria, and 25 patients with vivax malaria.